## First-Line Oral Therapy for Uncomplicated Enteric Fever ### Classification of Enteric Fever Severity **Key Point:** Uncomplicated enteric fever (stable vitals, no CNS signs, no complications) can be managed with oral fluoroquinolones as first-line in susceptible strains [cite:Harrison 21e Ch 157]. ### Why Fluoroquinolone for This Case 1. **Excellent oral bioavailability** — ofloxacin and ciprofloxacin achieve serum levels comparable to IV dosing 2. **Intracellular penetration** — reaches Peyer's patches and macrophages where Salmonella resides 3. **Outpatient feasibility** — oral route suitable for stable, non-severe disease 4. **Short duration** — 5–7 days sufficient for uncomplicated cases 5. **Cost-effective** — oral therapy reduces hospitalization burden ### Dosing Regimens for Uncomplicated Enteric Fever | Drug | Dose | Duration | Notes | | --- | --- | --- | --- | | Ofloxacin | 400 mg orally BD | 5–7 days | First-line for uncomplicated, susceptible | | Ciprofloxacin | 500 mg orally BD | 5–7 days | Alternative fluoroquinolone | | Azithromycin | 1 g daily (oral) | 5–7 days | Increasing use; good for resistant strains | | Cephalosporin | 2 g IV Q6–8H | 7–14 days | Reserved for severe/complicated disease | **High-Yield:** Fluoroquinolones are FIRST-LINE for **uncomplicated** enteric fever in susceptible organisms. Cephalosporins are reserved for **severe/complicated** cases. ### When to Use Cephalosporins Instead **Clinical Pearl:** Ceftriaxone is indicated when: - Fever >39°C, altered mental status, or signs of encephalopathy - Suspected perforation, peritonitis, or other complications - Immunocompromised host (HIV, malignancy) - Pregnancy (fluoroquinolones contraindicated) - Fluoroquinolone resistance documented ### Chloramphenicol: Obsolete **Warning:** Chloramphenicol is no longer recommended due to: - Widespread resistance in India (>50% in many regions) - Risk of aplastic anemia and bone marrow suppression - Inferior outcomes compared to modern agents - Poor CNS penetration relative to cephalosporins ### Azithromycin: Emerging Alternative **Key Point:** Azithromycin (1 g daily × 5–7 days) is increasingly used for uncomplicated enteric fever, especially in fluoroquinolone-resistant strains. However, fluoroquinolones remain the traditional first-line for susceptible organisms in uncomplicated disease.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.